Varex Imaging (NASDAQ:VREX) Receives Average Rating of “Hold” from Analysts

Shares of Varex Imaging (NASDAQ:VREXGet Free Report) have been assigned a consensus rating of “Hold” from the five brokerages that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $16.1667.

Several analysts recently commented on the stock. Wall Street Zen upgraded shares of Varex Imaging from a “hold” rating to a “buy” rating in a research report on Saturday, July 4th. Zacks Research downgraded shares of Varex Imaging from a “strong-buy” rating to a “hold” rating in a research report on Monday. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Varex Imaging in a research note on Wednesday, June 24th.

View Our Latest Report on VREX

Hedge Funds Weigh In On Varex Imaging

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Rockefeller Capital Management L.P. acquired a new stake in Varex Imaging during the 4th quarter worth approximately $27,000. Quarry LP acquired a new position in shares of Varex Imaging in the third quarter valued at approximately $64,000. BNP Paribas Financial Markets increased its holdings in shares of Varex Imaging by 18.5% in the second quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock valued at $113,000 after purchasing an additional 2,036 shares during the period. Aquatic Capital Management LLC acquired a new position in shares of Varex Imaging in the third quarter valued at approximately $117,000. Finally, Cerity Partners LLC purchased a new stake in shares of Varex Imaging during the second quarter worth approximately $123,000.

Varex Imaging Stock Performance

Shares of VREX stock opened at $11.07 on Friday. The stock’s 50-day moving average is $10.54 and its two-hundred day moving average is $11.58. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.43 and a current ratio of 3.20. Varex Imaging has a 1 year low of $6.76 and a 1 year high of $14.56. The firm has a market cap of $466.05 million, a price-to-earnings ratio of -5.54 and a beta of 0.90.

Varex Imaging (NASDAQ:VREXGet Free Report) last posted its earnings results on Thursday, May 7th. The company reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.01). The firm had revenue of $216.00 million during the quarter, compared to analysts’ expectations of $216.92 million. Varex Imaging had a negative net margin of 9.64% and a positive return on equity of 8.19%. Varex Imaging has set its Q3 2026 guidance at 0.150-0.300 EPS. Analysts predict that Varex Imaging will post 0.93 earnings per share for the current year.

About Varex Imaging

(Get Free Report)

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.

See Also

Analyst Recommendations for Varex Imaging (NASDAQ:VREX)

Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.